Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as being particularly good for the company. Last year, Ferring had record sales of ...

Ferring achieved total revenues of €2.3 billion in 2024, an increase of 7% over the previous year at actual exchange rates (AER) and 8% at constant exchange rates (CER). This above market growth ...

PARSIPPANY, N.J., October 18, 2024--Ferring Pharmaceuticals Illustrates Strong Commitment to Advancing Fertility Care at 2024 ASRM Annual Congress ...

Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin ...

This milestone represents significant progress in Ferring’s manufacturing capabilities to meet anticipated growth in demand for Adstiladrin® (nadofaragene firadenovec-vncg), a gene therapy for people ...

Ferring Pharmaceuticals and Posterity Health, a male fertility center of excellence, have partnered to launch a male fertility program. The two organizations announced the program’s debut on Thursday ...

Ferring senior director of marketing and strategic engagement Ali Castro says the company has set its sights on becoming a leader in the fertility space. “The Makers is our anthem,” she says. “What we ...

Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. We are leaders in reproductive ...

Ferring is the first company to successfully bring forward a first-in-class FDA approved live microbiome-based therapy to US patients. In addition, Ferring has the proven scale and ability to drive ...

UPDATED: December 7, 2023 at 3:45 PM CST Ferring Pharmaceuticals has informed the state that it will lay off 55 employees from its Roseville manufacturing, research and development plant.

Royalty Pharma to pay Ferring $300 million upfront and a potential $200 million milestone payment in exchange for royalties on the sales of Ferring’s intravesical gene therapy Adstiladrin ...

Shea Ferring was elevated to the role of chief technology officer at Firefly Aerospace, where he recently served as senior vice president of engineering responsible for leading its four key launch ...